Bioceres Crop Solutions Corp. (BIOX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Quarterly

0 50M 100M 150M Q2 '20: 62.3M Q2 '21: 48M Q1 '22: 66.4M Q2 '22: 92.3M Q3 '22: 68.2M Q4 '22: 101.6M Q1 '23: 126.8M Q2 '23: 94.5M Q3 '23: 93M Q4 '23: 105.1M Q1 '24: 116.2M Q2 '24: 140.3M Q3 '24: 84M Q4 '24: 124.3M Q1 '25: 92.6M Q2 '25: 98.9M Q3 '25: 59.6M Q4 '25: 74.4M Q1 '26: 77.4M Q2 '26: 73.7M Q2 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 20M 40M 60M Q3 '22: 23.7M Q4 '22: 36.5M Q1 '23: 51.7M Q2 '23: 35.3M Q3 '23: 57.5M Q4 '23: 40.2M Q1 '24: 45M Q2 '24: 51.5M Q3 '24: 42.6M Q4 '24: 47.4M Q1 '25: 37.5M Q2 '25: 41.5M Q3 '25: 23.8M Q4 '25: 25.2M Q1 '26: 36.3M Q2 '26: 26.7M Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income Quarterly

0 15M 30M 45M Q2 '19: 19M Q2 '20: 19.6M Q2 '21: 11.5M Q1 '22: 10M Q2 '22: 17.7M Q3 '22: 2.1M Q4 '22: 10M Q1 '23: 17M Q2 '23: 2.2M Q3 '23: 29.9M Q4 '23: 5.1M Q1 '24: 5.3M Q2 '24: 16.8M Q3 '24: 13.2M Q4 '24: 10.5M Q1 '25: 2.4M Q2 '25: 14.4M Q3 '25: 933.2K Q1 '26: 7.2M Q2 '26: 7.5M Q2 '20 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q2 '26

Net Income Quarterly

-210M -140M -70M 0 70M 140M 210M Q2 '19: 11.2M Q2 '20: 12.6M Q2 '21: 1.8M Q2 '22: 5.3M Q3 '22: -7M Q1 '23: 3.9M Q2 '23: -8.4M Q3 '23: 27.5M Q4 '23: -2.8M Q1 '24: -2.7M Q2 '24: 1.2M Q3 '24: 9.8M Q4 '24: -1M Q1 '25: -6.2M Q2 '25: 605.2K Q3 '25: -1.6M Q4 '25: -51.7M Q1 '26: -7.4M Q2 '26: -182.5M Q2 '19 Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 35M 70M 105M Q2 '20: 33M Q2 '21: 25.1M Q1 '22: 37.9M Q2 '22: 55.3M Q3 '22: 45.8M Q4 '22: 69.3M Q1 '23: 75.7M Q2 '23: 59.1M Q3 '23: 36.1M Q4 '23: 64.5M Q1 '24: 71.6M Q2 '24: 88.7M Q3 '24: 41.3M Q4 '24: 76.6M Q1 '25: 55.8M Q2 '25: 57.3M Q3 '25: 36.7M Q4 '25: 49.3M Q1 '26: 41.3M Q2 '26: 47.2M Q2 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '22: 7.8M Q1 '23: -32.4M Q2 '23: 41.3M Q3 '23: 2.2M Q4 '23: -8.5M Q1 '24: 14.7M Q2 '24: 21.1M Q3 '24: -17.4M Q4 '24: 23.3M Q1 '25: 5.2M Q2 '25: -5.4M Q3 '25: 23.3M Q4 '25: 26.8M Q1 '26: 14.4M Q2 '26: 17.4M Q3 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Free Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '22: 6.6M Q1 '23: -33.8M Q2 '23: 38.9M Q3 '23: -1.3M Q4 '23: -12.5M Q1 '24: 10.7M Q2 '24: 19M Q3 '24: -19.1M Q4 '24: 21.2M Q1 '25: 3.9M Q2 '25: -6.9M Q3 '25: 20.9M Q4 '25: 26.3M Q1 '26: 13.7M Q2 '26: 17.4M Q3 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '20: 36.1M Q2 '21: 39M Q2 '22: 42.4M Q3 '22: 41.1M Q1 '23: 61.7M Q2 '23: 61.7M Q3 '23: 63.1M Q1 '24: 62.8M Q2 '24: 63.9M Q3 '24: 66.8M Q1 '25: 62.9M Q2 '25: 63.2M Q3 '25: 62.8M Q1 '26: 63.4M Q2 '26: 63.5M Q2 '20 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '22: -0.17 Q1 '24: 0.22 Q2 '26: -3.78 Q4 '22 Q1 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.